Compare ARK Genomic Revolution ETF (ARKG) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs NextEra Energy, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while NextEra Energy, Inc. trades at $88.08 (market cap $183.45B). The key difference: NextEra Energy, Inc. pays a 2.83% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, NextEra Energy, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | NEE | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $97.88 |
52-Week Low | $23.09 | $69.77 |
Market Cap | — | $183.45B |
Enterprise Value | — | $285.85B |
Dividend Yield | — | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
NextEra Energy (NEE) trades at $87.96, up 0.99% on the day, with a bearish technical signal despite positive earnings momentum. The company reported strong Q1 2026 EPS of $1.09, beating expectations, and maintains robust profitability with a 29.37% net income margin. Recent news highlights the Dominion deal as a major catalyst, while analyst consensus remains strongly bullish with a $104.43 price target representing 19% upside potential.
NEE presents a compelling long-term investment opportunity driven by clean energy demand and strategic partnerships, though near-term technical weakness and rising debt levels warrant caution. The stock's current valuation at 22.32x P/E appears reasonable given growth prospects, but regulatory uncertainty from recent acquisitions and capital-intensive operations pose execution risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
